Information About This Study:
Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis.
Open to Volunteers
More information can be found at: https://www.clinicaltrials.gov/ . ClinicalTrials.gov is a registry of clinical trials run by the United States National Library of Medicine at the National Institutes of Health.